New Antibodies to HIV Found
A pair of powerful new antibodies to HIV has been found, possibly bringing us a step closer to a vaccine against AIDS. Although animal or human trials are likely to be years away, with this discovery researchers can work to find exactly how these antibodies bind to HIV, the virus that causes AIDS.A pair of powerful new antibodies to HIV has been found, possibly bringing us a step closer to a vaccine against AIDS. Although animal or human trials are likely to be years away, with this discovery researchers can work to find exactly how these antibodies bind to HIV, the virus that causes AIDS.
Strong Journalism, Rooted in TruthThe Wall Street Journal:
An international team of researchers has discovered a pair of powerful new antibodies to HIV, providing fresh leads in the quest for a vaccine against AIDS.
The two HIV antibodies, reported in a study to appear in the journal Science on Friday, are the first of their kind to have been identified in more than a decade. They are “broadly neutralizing,” which means they can target most of the many thousands of HIV strains.
Truthdig remains committed to deep reporting that challenges power and brings hidden stories to the surface.
Support independent journalism.
Media
Choosing between a rightwing billionaire and the Netflix slop factory is grim, thankless work.
Environment
The research centers are a key part of the unappreciated infrastructure that supports the health of pollinators and the nation’s food supply.
Politics
We are facing the biggest test of our democracy since the Civil War.
Global Voices
Surviving violent displacement wasn’t enough — Rohingya women in Cox’s Bazar, Bangladesh now face pressure and coercion over their most personal decisions.
Ear to the Ground
Immigration and Customs Enforcement agents have yet more blood on their hands in recent weeks.
Opinion
The refrain has great political utility in U.S. politics—allowing advocates to check a box and avoid the hard realities of a changing relationship with Israel.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.